A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation
Clinical trial NCT01493557 · COMPLETED
Trial details
- NCT number
- NCT01493557
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2014-07-01
- Enrollment
- 1067
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.